Cartesian Therapeutics, Inc. (RNAC)
NASDAQ: RNAC · IEX Real-Time Price · USD
21.03
+0.13 (0.62%)
At close: Apr 26, 2024, 4:00 PM
21.49
+0.46 (2.19%)
After-hours: Apr 26, 2024, 4:26 PM EDT
Cartesian Therapeutics Market Cap
Cartesian Therapeutics has a market cap or net worth of $373.91 million as of April 26, 2024. Its market cap has increased by 110.30% in one year.
Market Cap
373.91M
Enterprise Value
307.95M
1-Year Change
110.30%
Ranking
Category
Stock Price
$21.03
Market Cap Chart
Since June 22, 2016, Cartesian Therapeutics's market cap has increased from $236.80M to $373.91M, an increase of 57.90%. That is a compound annual growth rate of 5.99%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 113.50M | 0.62% |
Apr 25, 2024 | 112.80M | 0.80% |
Apr 24, 2024 | 111.90M | 0.63% |
Apr 23, 2024 | 111.20M | 12.78% |
Apr 22, 2024 | 98.60M | 1.96% |
Apr 19, 2024 | 96.70M | 3.64% |
Apr 18, 2024 | 93.30M | -6.61% |
Apr 17, 2024 | 99.90M | -1.38% |
Apr 16, 2024 | 101.30M | -1.17% |
Apr 15, 2024 | 102.50M | -2.10% |
Apr 12, 2024 | 104.70M | 7.49% |
Apr 11, 2024 | 97.40M | 10.56% |
Apr 10, 2024 | 88.10M | 16.69% |
Apr 9, 2024 | 75.50M | 6.64% |
Apr 8, 2024 | 70.80M | -1.53% |
Apr 5, 2024 | 71.90M | -11.89% |
Apr 4, 2024 | 81.60M | 2.77% |
Apr 3, 2024 | 79.40M | -7.46% |
Apr 2, 2024 | 85.80M | -5.40% |
Apr 1, 2024 | 90.70M | -13.87% |
Mar 28, 2024 | 105.30M | -1.59% |
Mar 27, 2024 | 107.00M | 5.84% |
Mar 26, 2024 | 101.10M | -8.17% |
Mar 25, 2024 | 110.10M | -4.84% |
Mar 22, 2024 | 115.70M | 1.49% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Anika Therapeutics | 374.37M |
Surmodics | 372.56M |
Harrow Health | 372.37M |
Heron Therapeutics | 368.31M |
Aquestive Therapeutics | 366.17M |
Zynex | 360.63M |
ADC Therapeutics | 359.41M |
Corbus Pharmaceuticals Holdings | 359.39M |